Lamepil 25mg Tablet contains Lamotrigine, an anticonvulsant medication primarily used in the management of epilepsy and bipolar disorder. Lamotrigine acts by stabilizing neuronal membranes and modulating voltage-sensitive sodium channels, thereby inhibiting the release of excitatory neurotransmitters such as glutamate. This mechanism helps in reducing the frequency and severity of seizures in patients with partial seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. Additionally, Lamotrigine is effective as a mood stabilizer, particularly in preventing depressive episodes in bipolar disorder. Lamepil 25mg is typically administered orally, with dosage individualized based on patient response and clinical condition. It is important to initiate treatment at a low dose and titrate gradually to minimize the risk of serious skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Common side effects may include dizziness, headache, blurred vision, and gastrointestinal disturbances. Patients should be monitored regularly for adverse effects and therapeutic efficacy. Lamepil should be used with caution in patients with hepatic or renal impairment and may interact with other antiepileptic drugs. It is contraindicated in individuals with known hypersensitivity to Lamotrigine or any tablet components. Proper adherence to prescribed dosing and medical supervision is essential for optimal therapeutic outcomes.